An open-label trial of reboxetine in children and adolescents with attention-deficit/hyperactivity disorder.
about
A systematic review of reboxetine for treating patients with attention deficit hyperactivity disorderEfficacy of reboxetine in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled clinical trial.Effectiveness of reboxetine in treatment of outpatient children and adolescents with attention deficit-hyperactivity disorder with comorbid anxiety disorders.
P2860
An open-label trial of reboxetine in children and adolescents with attention-deficit/hyperactivity disorder.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
An open-label trial of reboxet ...... eficit/hyperactivity disorder.
@ast
An open-label trial of reboxet ...... eficit/hyperactivity disorder.
@en
An open-label trial of reboxet ...... eficit/hyperactivity disorder.
@nl
type
label
An open-label trial of reboxet ...... eficit/hyperactivity disorder.
@ast
An open-label trial of reboxet ...... eficit/hyperactivity disorder.
@en
An open-label trial of reboxet ...... eficit/hyperactivity disorder.
@nl
prefLabel
An open-label trial of reboxet ...... eficit/hyperactivity disorder.
@ast
An open-label trial of reboxet ...... eficit/hyperactivity disorder.
@en
An open-label trial of reboxet ...... eficit/hyperactivity disorder.
@nl
P2093
P356
P1476
An open-label trial of reboxet ...... eficit/hyperactivity disorder.
@en
P2093
Mehdi Tehrani-Doost
Shirin Moallemi
Zahra Shahrivar
P304
P356
10.1089/CAP.2006.0034
P577
2008-04-01T00:00:00Z